The research, led by L. J. Getz, A. L. Qian, Vivian Liu and colleagues, focused on a central challenge in phage biology: how bacteria detect viral DNA when that DNA has been chemically modified to evade immune surveillance. Many phages alter their genomes by replacing standard nucleobases or adding chemical groups to them. These modifications can protect viral DNA from restriction enzymes and other bacterial defences, but they also create unusual molecular patterns. The new findings show that bacteria can exploit those patterns through specialized DNA glycosylases that selectively recognize modified bases in phage genomes.

DNA glycosylases are best known as components of DNA repair pathways. In conventional repair, a glycosylase scans DNA and identifies a damaged or chemically altered base, then cleaves the bond connecting that base to the sugar-phosphate backbone. This generates an abasic site, which can subsequently be processed by additional repair enzymes. By removing the abnormal base rather than cutting the DNA backbone directly, glycosylases provide a precise mechanism for correcting chemical damage while limiting unnecessary disruption to the chromosome.

The study shows that some members of this enzyme class have been repurposed for antiviral defence. Using structure-guided discovery, the researchers identified two widespread families of anti-phage glycosylases, named Dag1 and Dag2. Although these proteins are related to the broader DNA glycosylase fold, their biological role is distinct from routine repair. Dag1 and Dag2 act as immune effectors that preferentially target phage DNA containing modified guanine bases, allowing bacteria to distinguish invading genomes from their own unmodified genetic material.

This selectivity is important because a defence enzyme that indiscriminately damaged every chemically unusual base could also threaten the host chromosome. Phage genomes, however, may carry modifications that are rare or absent in bacterial DNA. By recognizing these non-canonical forms of guanine, Dag1 and Dag2 can focus their activity on viral DNA during infection. The resulting base removal is expected to produce lesions that compromise the integrity or replication of the phage genome, thereby reducing the virus’s ability to generate progeny.

Rather than relying solely on sequence comparisons, the researchers used the conserved three-dimensional architecture of glycosylases as a guide for finding additional defence proteins. This approach allowed them to search for structurally related enzymes that may have diverged so extensively at the sequence level that conventional genome-mining methods would overlook them. The resulting collection included numerous defence-associated glycosylases, suggesting that the antiviral use of this fold is not limited to Dag1 and Dag2 but represents a broad and diverse evolutionary strategy.

The diversity of these enzymes also points to a wider chemical contest between bacteria and phages. Phages are known to deploy an array of modified bases, including altered guanine and thymidine derivatives, to make their DNA resistant to bacterial nucleases and other immune mechanisms. In response, bacteria appear to have evolved glycosylases with different molecular specificities. The newly described systems collectively form a repertoire capable of targeting chemically modified phage DNA, potentially matching the variety of base modifications found across viral lineages.

The researchers further identified a distinct glycosylase superfamily associated with protection against phages carrying modified thymidine bases. Its separation from the Dag1 and Dag2 families indicates that bacteria have recruited more than one structural solution to the same broad problem: detecting and neutralizing viral genomes that contain non-standard nucleobases. The discovery expands the known functional range of glycosylases and illustrates how common biochemical frameworks can be adapted to recognize chemically distinct targets.

These findings have implications beyond the specific defence systems described in the study. Bacterial genomes contain many proteins whose functions remain unknown, particularly among rapidly evolving defence islands enriched in genes involved in phage resistance. Structure-guided analysis may reveal immune functions that are invisible to sequence-based annotation, helping researchers map the hidden architecture of bacterial antiviral biology. The work also underscores the evolutionary flexibility of DNA repair enzymes, which can be redeployed from preserving genetic information to attacking an invading genome.

As phage therapy, synthetic biology and microbiome research continue to develop, understanding these mechanisms could become increasingly important. Bacterial glycosylases may influence which phages can infect particular hosts, while phage base modifications may determine whether an infection succeeds or fails. The study establishes DNA glycosylases as a versatile class of bacterial immune proteins and demonstrates that the molecular signatures created by phage genome modification can become liabilities. In the continuing conflict between bacteria and viruses, chemical camouflage may therefore provide protection—but it can also reveal the invader to a precisely adapted cellular defence.

Subject of Research: Antiviral DNA glycosylases that recognize and damage chemically modified phage DNA.

Article Title: Antiviral defence is a conserved function of diverse bacterial DNA glycosylases

Article References: Getz, L.J., Qian, A.L., Vivian Liu, Y. et al. Antiviral defence is a conserved function of diverse bacterial DNA glycosylases. Nature Microbiology (2026). https://doi.org/10.1038/s41564-026-02441-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41564-026-02441-0

Keywords: Bacteriophages, bacterial immunity, DNA glycosylases, modified DNA bases, phage defence, Dag1, Dag2, antiviral defence, genome modification, microbial evolution

At the heart of bacterial immunity lies an arsenal of molecular tools designed to identify, bind, and destroy foreign nucleic acids. Classic examples include restriction–modification systems, which recognize specific DNA sequences and selectively cleave unmodified foreign DNA, and CRISPR–Cas systems, which utilize RNA-guided endonucleases for sequence-specific targeting. Intriguingly, bioinformatics has recently uncovered a plethora of novel antiphage operons featuring a co-occurrence of nuclease and nucleoside triphosphatase (NTPase) proteins encoded within the same genomic loci. The modularity and conservation of these nuclease–NTPase pairs hinted at a common functional theme, yet their molecular mechanisms remained obscure until now.

The study spearheaded by Ragucci et al. presents an ambitious large-scale approach that integrates genomic bioinformatics, biochemical purification, and in vitro functional assays to characterize sixteen representative nuclease–NTPase systems from phylogenetically diverse bacteria. This comprehensive effort revealed that the physical interaction between these two components is a defining characteristic of functional complexes. Specifically, the formation of stable protein–protein complexes is essential for efficient nucleic acid recognition and cleavage, highlighting a sophisticated regulatory mechanism that ensures defense activation only upon phage invasion, thereby minimizing collateral damage to the host genome.

Detailed biochemical characterizations of several systems, including those from Pseudomonas aeruginosa (PaAbpAB), Bacteroides thetaiotaomicron (BtHachiman), and Escherichia coli (EcPD-T4-8), demonstrated that their nucleases exhibit highly degenerate recognition site preferences. Unlike restriction enzymes that cleave specific palindromic sequences, these nucleases indiscriminately degrade nucleic acids over a broad range, enabling a formidable antiviral response capable of targeting diverse phages with varying genomic sequences. This promiscuity likely provides a significant evolutionary advantage, allowing bacteria to combat rapidly mutating viral genomes without the need for precise sequence recognition.

Adding another layer of complexity, the study unveiled the Azaca system, which diverges from the broad-spectrum strategy by using a finely tuned molecular recognition mechanism. This system specifically detects modified phage genomic DNA — a modification often employed by phages to evade host restriction systems — and triggers targeted nuclease activity. This finding spotlights a sophisticated surveillance strategy where bacterial immunity adapts not only to generic nucleic acid invasion but also to chemical modifications introduced by viral adversaries, underscoring the evolutionary dynamism of bacterial immune systems.

The functional interplay between the nuclease and NTPase subunits is hypothesized to regulate nuclease activity spatially and temporally. The NTPase, typically hydrolyzing ATP or GTP, may provide the energy input required for conformational changes or nucleic acid translocation, thereby activating or directing the nuclease component toward the invading phage genome. Such energy-dependent regulation ensures precision in dismantling phage DNA while safeguarding the host’s genetic material, reflecting an elegant molecular switch that balances immunity with self-preservation.

This study also challenges earlier assumptions that bacterial defense systems rely solely on sequence-specific recognition. Instead, it broadens the paradigm to include mechanisms based on structural recognition, modification-dependent targeting, and cooperative protein complex formation. Through experimental reconstitution of nucleic acid degradation in vitro, the authors provide compelling mechanistic evidence that diverse nuclease–NTPase systems operate through conserved molecular features despite their functional diversity, emphasizing a common evolutionary blueprint in bacterial defense.

A notable technical advancement in this work is the integration of comparative cell biology with high-resolution biochemical assays. By expressing these systems in heterologous bacterial hosts and monitoring phage susceptibility, the researchers linked molecular activity with phenotypic outcomes. This integrative approach offers a powerful platform for dissecting the functional nuances of antiphage defense mechanisms and paves the way for rational engineering of synthetic immunity modules with potential applications in biotechnology and phage therapy.

Beyond broadening our fundamental understanding, the uncovering of nuclease–NTPase systems might have profound implications for the development of next-generation antibacterial strategies. As antibiotic resistance rises, bacteriophages are gaining attention as alternative therapeutics. Understanding bacterial immune systems at a molecular level is critical for designing phages able to circumvent bacterial defenses or, conversely, for engineering bacteria with enhanced immunity to phage predation in industrial microbial processes.

Moreover, the modular nature of nuclease–NTPase systems inspires potential biotechnological innovation. By harnessing the broad nucleic acid degradation capabilities or the modification-specific targeting, these systems could be repurposed as versatile molecular tools for gene editing, nucleic acid detection, or controlled genome degradation. Their inherent regulatory mechanisms may allow fine-tuned control in synthetic biology applications, emphasizing the translational potential of these newly uncovered antiphage systems.

This study also highlights the pervasive influence of mobile genetic elements in shaping bacterial immunity. Many nuclease–NTPase operons were found clustered with genes encoding other defense components or mobile elements, suggesting horizontal gene transfer plays a vital role in disseminating defense capabilities across microbial communities. Such genetic mobility fuels bacterial adaptability and resilience in the face of ever-evolving viral threats, portraying a dynamic evolutionary landscape.

While the current work elucidates critical aspects of nuclease–NTPase systems in vitro and in bacterial hosts, several intriguing questions remain open. Future research may focus on high-resolution structural studies to visualize the architecture of these complexes and capture conformational states during nucleic acid engagement. Additionally, in vivo studies exploring regulation, interactions with other cellular pathways, and the ecological impact of these systems in natural bacterial populations will be essential to fully understand their biological roles.

The discovery of the Azaca system’s modification-dependent targeting also prompts further investigation into the molecular basis of chemical recognition and discrimination of phage DNA modifications. Deciphering these molecular codes could unveil new dimensions of molecular sensing and immune evasion strategies employed by phages and bacteria alike, deepening the complexity of microbial warfare.

In conclusion, Ragucci and colleagues’ work represents a landmark contribution to the field of molecular microbiology, revealing that nuclease–NTPase antiphage defense systems leverage conserved, yet versatile, molecular features to orchestrate bacterial immunity. Their findings expand the vista of bacterial antiviral strategies beyond classical paradigms, revealing sophisticated, energy-dependent mechanisms of broad and specific nucleic acid degradation. As the battle between microbes and their viruses continues unabated, insights from such studies will be indispensable in understanding microbial ecology, evolutionary biology, and the development of innovative biomedical technologies.

Subject of Research:
The molecular mechanisms and functional diversity of nuclease–NTPase antiphage defense systems in bacteria.

Article Title:
Nuclease–NTPase antiphage defence systems use conserved molecular features to control bacterial immunity.

Article References:
Ragucci, A.E., Antine, S.P., Leviss, E.M. et al. Nuclease–NTPase antiphage defence systems use conserved molecular features to control bacterial immunity. Nat Microbiol (2026). https://doi.org/10.1038/s41564-026-02312-8

DOI: https://doi.org/10.1038/s41564-026-02312-8